Last reviewed · How we verify

NCT05949138

Clinical Data Collection and Evaluation of ECG-Less Cardiac CT

Completed Last updated 7 June 2024
What this trial tests

trial testing ECG-Less Cardiac CT using SmartPhase in Cardiac CT in 56 participants. Completed in 3 November 2023.

Timeline
11 September 2023
Primary endpoint
1 November 2023
3 November 2023

Quick facts

Lead sponsorGE Healthcare
StatusCompleted
Study typeOBSERVATIONAL
Enrollment56
Start date11 September 2023
Primary completion1 November 2023
Estimated completion3 November 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

GE Healthcare — full company profile →

Who can join

18 and older, any sex, with Cardiac CT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to collect CT scan data without ECG-leads attached to the human subject. This data is intended to represent a typical range of clinical scenarios in which Cardiac CT imaging is used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other GE Healthcare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05949138.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing